Company: AGIO
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0001439222-25-000036
Chunk: 116

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 8
Chunk 116
---
 were classified as Level 3 at any point during the three months ended March 31, 2025.

4. Marketable Securities

Our marketable securities are classified as available-for-sale pursuant to ASC 320, Investments – Debt and Equity Securities, and are recorded at fair value. Unrealized gains and losses are included as a component of accumulated other comprehensive income (loss) in the condensed consolidated balance sheets and statements of stockholders’ equity, and a component of total 

8

comprehensive income (loss) in the condensed consolidated statements of comprehensive loss, until realized. Unrealized losses are evaluated for impairment under ASC 326, Financial Instruments - Credit Losses, to determine if the impairment is credit-related or noncredit-related. Credit-related impairment is recognized as an allowance on the condensed consolidated balance sheets with a corresponding adjustment to earnings, and noncredit-related impairment is recognized in other comprehensive income, net of taxes. Realized gains and losses are included in investment income on a specific-identification basis. There were no material realized gains or losses on marketable securities for the three months ended March 31, 2025 or 2024.Marketable securities at March 31, 2025 consisted of the following:(In thousands)AmortizedCostUnrealizedGainsUnrealizedLossesFairValueCurrent:Certificates of deposit$6,758 $5 $— $6,763 U.S. Treasuries127,826 95 (102)127,819 Government securities157,990 27 (88)157,929 Corporate debt securities521,864 278 (242)521,900 Total Current814,438 405 (432)814,411 Non-current:U.S. Treasuries105,858 476 (42)106,292 Government securities114,181 27 (173)114,035 Corporate debt securities310,822 390 (286)310,926 Total Non-current530,861 893 (501)531,253 Total marketable securities$1,345,299 $1,298 $(933)$1,345,664 Marketable securities at December 31, 2024 consisted of the following:(In thousands)AmortizedCostUnrealizedGainsUnrealizedLossesFairValueCurrent:Certificates of deposit$10,374 $11 $— $10,385 U.S. Treasuries173,465 153